Back to Search
DONALD TINDALL, M.D.
M.D.
General Practice Physician
NPI: 1902973399Individual
Specialties, Licenses & Credentials
General Practice PhysicianPrimary
General Practice
Code: 208D00000X
ME 21406(FL)
Research & Publications (20)
Androgen modulation of coregulator expression in prostate cancer cells.
PMID 19164447·Mol Endocrinol·2009
8-other
Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder.
PMID 18845648·Endocr Relat Cancer·2009
8-other
Expression of immunosuppresive B7-H3 ligand by hormone-treated prostate cancer tumors and metastases.
PMID 19276267·Clin Cancer Res·2009
8-other
Effects of the 5 alpha-reductase inhibitor dutasteride on gene expression in prostate cancer xenografts.
PMID 19676081·Prostate·2009
7-preclinical
Hypermethylation of genes for diagnosis and risk stratification of prostate cancer.
PMID 19229700·Cancer Invest·2009
8-other
Unraveling the complexities of androgen receptor signaling in prostate cancer cells.
PMID 19345321·Cancer Cell·2009
7-preclinical
Vascular endothelial growth factor-C protects prostate cancer cells from oxidative stress by the activation of mammalian target of rapamycin complex-2 and AKT-1.
PMID 19638584·Cancer Res·2009
8-other
The role of the transcriptional coactivator p300 in prostate cancer progression.
PMID 18497079·Adv Exp Med Biol·2008
8-other
Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance.
PMID 18593950·Cancer Res·2008
7-preclinical
Induction of FLIP expression by androgens protects prostate cancer cells from TRAIL-mediated apoptosis.
PMID 18726983·Prostate·2008
7-preclinical
Gene silencing for epidermal growth factor receptor variant III induces cell-specific cytotoxicity.
PMID 19001441·Mol Cancer Ther·2008
7-preclinical
Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression.
PMID 19160488·Nat Cell Biol·2008
8-other
The rationale for inhibiting 5alpha-reductase isoenzymes in the prevention and treatment of prostate cancer.
PMID 18280514·J Urol·2008
6-review
Type 1 and type 2 5alpha-reductase expression in the development and progression of prostate cancer.
PMID 18006217·Eur Urol·2008
6-review
Loss of NKX3.1 favors vascular endothelial growth factor-C expression in prostate cancer.
PMID 18974119·Cancer Res·2008
8-other
Accuracy of voice-announcement pedometers for youth with visual impairment.
PMID 17916918·Adapt Phys Activ Q·2007
4-observational
Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex.
PMID 17940184·Endocr Rev·2007
6-review
Selective role of an NH2-terminal WxxLF motif for aberrant androgen receptor activation in androgen depletion independent prostate cancer cells.
PMID 17942941·Cancer Res·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 720 N BAY ST, SUITE 11
EUSTIS, FL 32726 - Phone
- (352) 483-1600
Quick Facts
- NPI
- 1902973399
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile